Yang Jingjing, Tang Aiguo, Ma Junfen, Sun Xiaoxu, Ming Liang
a Department of Clinical Laboratory , The First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Laboratory Medicine , Zhengzhou , Henan , China.
b Department of Clinical Laboratory , The Second Xiangya Hospital, Central South University , Changsha , Hunan , China.
Scand J Clin Lab Invest. 2019 Feb-Apr;79(1-2):71-74. doi: 10.1080/00365513.2018.1555855. Epub 2019 Feb 6.
Tumor markers are noninvasive diagnostic tools for cancer. Their abnormal expression often occurs earlier than clinical symptoms or other detection signals. Appropriate reference intervals (RIs) of tumor markers are important for health evaluation, cancer diagnosis, therapy monitoring and prognosis assessment. In this study, we aimed to establish the RIs of cancer antigen 125 (CA125), CA15-3, CA19-9, CA72-4, alpha fetoprotein (AFP), carcino-embryonic antigen (CEA), neuron-specific enolase (NSE) and cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) in apparently healthy Henan population. A total of 1705 apparently healthy participants (21-89 years) were recruited from five representative geographical regions in Henan province. Nonparametric 95th percentile intervals were used to define the RIs of CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. The test results of CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1 can traceable to reference measurement procedures. The age- and gender-specific RIs of the tumor markers were established. We established age- and gender-specific RIs for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. The newly established RIs should be more suitable for Henan population. It will be valuable for clinicians to make a medical diagnosis, therapeutic management decision and other physiological assessment.
肿瘤标志物是癌症的非侵入性诊断工具。它们的异常表达通常比临床症状或其他检测信号出现得更早。肿瘤标志物的适当参考区间(RIs)对于健康评估、癌症诊断、治疗监测和预后评估非常重要。在本研究中,我们旨在建立河南省健康人群中癌抗原125(CA125)、CA15-3、CA19-9、CA72-4、甲胎蛋白(AFP)、癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)和细胞角蛋白19片段抗原21-1(CYFRA21-1)的参考区间。从河南省五个具有代表性的地理区域招募了总共1705名健康参与者(21-89岁)。采用非参数第95百分位数区间来定义CA125、CA15-3、CA19-9、CA72-4、AFP、CEA、NSE和CYFRA21-1的参考区间。CA125、CA15-3、CA19-9、CA72-4、AFP、CEA、NSE和CYFRA21-1的检测结果可溯源至参考测量程序。建立了肿瘤标志物的年龄和性别特异性参考区间。我们建立了CA125、CA15-3、CA19-9、CA72-4、AFP、CEA、NSE和CYFRA21-1的年龄和性别特异性参考区间。新建立的参考区间应更适合河南人群。这将有助于临床医生进行医学诊断、治疗管理决策和其他生理评估。